The medico-legal expert witness space appears to have started to
become rather crowded in recent years, with an increasing number of
health professionals believing this to be a desired area of practice,
some virtually immediately postgraduation. As the pool of alleged expertise
grows however, so too do the risks to the reputation of the professional
domain under which an expert is registered and the quality of the
evidence provided if the duties of an expert witness are not properly
respected and understood.
We welcome you to come and read through our latest, March, edition of Modern Medicine.
This month we have a jam packed edition for you. Our features this month include; Opthalmology, Cardiology, Woundcare, Neurology & CNS and many more.
We encourage all of our readers to complete the CPD questionnaire for this edition, this can be done on the answer-form included in the magazine, or on ourwebsite CPD system.
Modern Medicine,the journal that’s with you wherever you go.
Patients with opioid dependence are a common presentation in
general practice. Stable patients taking medications for pain who
are opioid dependent should ideally be managed in routine
general practice. As well as usual primary care, opioid use or opioid
substitution treatment needs monitoring in these patients.
Shared care with pain and addiction specialists is an effective way for
GPs to provide care to patients with addiction.
The introduction of interferon beta therapies more than 20 years ago marked a milestone in the treatment of
relapsing-remitting multiple sclerosis (RRMS) with a significant impact on the approach to modern multiple
sclerosis (MS) care. The continuous development of interferon’s over the past two decades outlines a journey
with increased understanding of the pharmacodynamics and pharmacokinetic mechanisms of interferons, leading
to innovative formulations with an improved benefit/risk profile.
The construct of major depressive disorder makes no etiological
assumptions about populations with diverse symptom clusters.
“Depressed mood” and “loss of interest or pleasure in nearly all
activities” are core features of a major depressive episode, though
a strong case can be made to pay increasing attention to symptoms of
fatigue, sleep disturbance, anxiety and neurocognitive and sexual
dysfunction in the diagnosis. Mood, guilt, work and interest,
as well as psychic anxiety, are consistently identified across
validated subscales of the Hamilton Depression Rating Scale as
prevalent and sensitive to change with existing treatments.
Subarachnoid haemorrhage (SAH) due to a ruptured cerebral aneurysm is a potentially fatal condition that
presents as headache. A raised index of suspicion must exist for all patients with sudden, severe headache with or
without associated symptoms. Initial investigation of suspected SAH should be a
noncontrast CT scan. Management of SAH is increasingly becoming endovascular. The outcome for patients with
no or only a mild global or focal neurological deficit on presentation has improved, but pre-hospital mortality and
disability from the initial haemorrhage remains a problem. Unruptured asymptomatic aneurysms are not an urgent
scenario and can be dealt with in consultative outpatient fashion.
Globally, coronary artery disease (CAD) is the leading cause of death
and is predicted to remain so for the foreseeable future. Stable angina
pectoris is defined as chest pain that develops when the heart rate
rises, for example, during intense sports or exciting emotions. In such
situations, the blood supply cannot meet the myocardial metabolism
needs, thus leading to angina.
Pulmonary arterial hypertension (PAH) is a life-threatening disease of the small pulmonary arteries that progresses
to right heart failure and death if untreated. Early diagnosis and timely initiation of therapy is crucial to good
outcomes. PAH must be considered in any patient with unexplained breathlessness. Unexplained breathlessness
should be viewed just as seriously as chest pain. Definitive diagnosis requires right heart catheterisation.
Annual screening for PAH should be undertaken in high risk patient groups, such as those with systemic sclerosis
or past repair of a septal defect. Many efficacious drug therapies are available and combination therapy is now
the evidence-based standard of care.
The introduction of anti-vascular endothelial growth factor (anti-VEGF) has significantly reduced visual loss due to
neovascular age-related macular degeneration (n-AMD). However there are significant inter-individual differences
in response to an anti-VEGF agent due to a variety of factors including patient’s age, lesion characteristics,
lesion duration, baseline visual acuity (VA) and the presence of particular genotype risk alleles.
We welcome you to come and read through our latest, February, edition of Modern Medicine.
This month we have a jam packed edition for you. Our features this month include; Diabetes, Gastroenterology, Immunisation, Ethics and many more.
We encourage all of our readers to complete the CPD questionnaire for this edition, this can be done on the answer-form included in the magazine, or on ourwebsite CPD system.
Modern Medicine,the journal that’s with you wherever you go.
